In focus · trending topic

cancer diagnostic

8 stories · following the connections

bioAffinity Technologies Joins Early Detection Research Network

By Nasdaq OMXMar 1, 2018, 4:00 PM UTC

OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants

By Nasdaq OMXJan 11, 2018, 6:39 PM UTC

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

By Nasdaq OMXDec 21, 2017, 11:55 AM UTC

bioAffinity Technologies Welcomes New Board Members

By Nasdaq OMXNov 29, 2017, 4:00 PM UTC

bioAffinity Technologies Adds Four Scientists to Research & Commercialization Team

By Nasdaq OMXJun 28, 2017, 6:00 PM UTC

bioAffinity Technologies Announces Award of European Union Patent

By Nasdaq OMXMay 3, 2017, 6:00 PM UTC

bioAffinity Awarded New Patent; Company’s Patent Portfolio Continues to Expand

By Nasdaq OMXAug 24, 2016, 1:00 PM UTC

bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference

By Nasdaq OMXApr 12, 2016, 1:00 PM UTC